ArticleCancer medicine2024

Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.

Meiying Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.